Case Reports
doi: 10.1179/crn.2004.041.
Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report
Affiliations
- PMID: 15532318
- DOI: 10.1179/crn.2004.041
Item in Clipboard
Case Reports
Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report
Cranio.
2004 Oct.
Abstract
The following case report depicts the management of a patient suffering with a jaw opening oromandibular dystonia using a combination of botulinum toxin injections, zolpidem, and relaxation procedures. Eventually the botulinum toxin injections were eliminated, and the patient was maintained with only zolpidem and relaxation procedures.
Similar articles
-
Recurrent TMJ Dislocation Managed with Botulinum Toxin Type A Injections in a Pediatric Patient.Pediatr Dent. 2015 Jan-Feb;37(1):65-9. Pediatr Dent. 2015. PMID: 25685976
-
Botulinum toxin treatment for upper airway collapse resulting from temporomandibular joint dislocation due to jaw-opening dystonia.Cranio. 2006 Jul;24(3):217-22. doi: 10.1179/crn.2006.035. Cranio. 2006. PMID: 16933464
-
Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.Br J Oral Maxillofac Surg. 2010 Jun;48(4):281-4. doi: 10.1016/j.bjoms.2009.07.014. Epub 2009 Aug 7. Br J Oral Maxillofac Surg. 2010. PMID: 19665263
-
EMG guided lateral pterygoid muscle Botox--A injection for chronic temporomandibular joint dislocation: 2 patient case report.J Indiana Dent Assoc. 2014 Winter;93(1):22-6. J Indiana Dent Assoc. 2014. PMID: 24683765 Review. No abstract available.
-
Treatment of temporomandibular disorders with botulinum toxin.Clin J Pain. 2002 Nov-Dec;18(6 Suppl):S198-203. doi: 10.1097/00002508-200211001-00013. Clin J Pain. 2002. PMID: 12569969 Review.
Cited by
-
Movement disorders of the mouth: a review of the common phenomenologies.J Neurol. 2022 Nov;269(11):5812-5830. doi: 10.1007/s00415-022-11299-1. Epub 2022 Jul 29. J Neurol. 2022. PMID: 35904592 Review.
-
Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.Parkinsons Dis. 2016;2016:2531812. doi: 10.1155/2016/2531812. Epub 2016 May 17. Parkinsons Dis. 2016. PMID: 27293955 Free PMC article. Review.
-
Zolpidem for the Treatment of Dystonia.Front Neurol. 2019 Jul 17;10:779. doi: 10.3389/fneur.2019.00779. eCollection 2019. Front Neurol. 2019. PMID: 31379728 Free PMC article.
-
The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.J Dent (Shiraz). 2017 Sep;18(3):157-164. J Dent (Shiraz). 2017. PMID: 29034269 Free PMC article. Review.
-
Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.Front Neurol. 2022 May 3;13:837023. doi: 10.3389/fneur.2022.837023. eCollection 2022. Front Neurol. 2022. PMID: 35592470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
